Meta-analysis of the efficacy of glucagon-like peptide-1 receptor agonists in the treatment of diabetic nephropathy by Ze-jin Liao, Jin-hu Chen, Li-hua Ni, Xiao-yan Wu

Subjects: “…glucagon-like peptide-1 receptor agonist…”
Get full text

Glucagon-like peptide-1 receptor agonist use is associated with reduced risk of out-of-hospital cardiac arrest in women with type 2 diabetes: A nationwide nested case-control study by Talip E. Eroglu, Ruben Coronel, Fredrik Folke, Gunnar Gislason

Subjects: Get full text

Semaglutide and the Retina by Zachary T. Bloomgarden

Subjects: Get full text

Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA... by Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, Jun Takeuchi, Miki Ito, Hiroyoshi Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Akinobu Nakamura, Tatsuya Atsumi

Subjects: Get full text

Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease by Melinda Urkon, Elek Ferencz, József Attila Szász, Monica Iudita Maria Szabo, Károly Orbán-Kis, Szabolcs Szatmári, Előd Ernő Nagy

Subjects: Get full text

Comparison of Effects of Glucagon-Like Peptide-1 Receptor Agonists Compared to Long-Acting Insulin, Added to Oral Anti-Diabetic Agents on Self-Management Behaviors, Anxiety, and Sl... by Song X, Yang X, Liu Q, Bian X, Gao L, Tao J

Subjects: “…glucagon-like peptide-1 receptor agonist…”
Get full text

Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials by Obieda Altobaishat, Ahmed Farid Gadelmawla, Elsayed Balbaa, Mustafa Turkmani, Mohamed Abouzid

Subjects: “…Glucagon-like peptide-1 receptor agonist…”
Get full text

The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions by Areesha Moiz, Kristian B. Filion, Michael A. Tsoukas, Oriana H.Y. Yu, Tricia M. Peters, Mark J. Eisenberg

Subjects: “…Glucagon-like peptide-1 receptor agonist…”
Get full text

One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists by Hirotaka Watada

Subjects: Get full text

Obesity and heart failure with preserved ejection fraction: focus on new drugs and future direction in medical treatment by Se-Eun Kim, Byung-Su Yoo

Subjects: Get full text

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medic... by Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa Sannidhi, Fatima Cody Stanford, Emily A. Callahan

Subjects: Get full text

Population profile and glycemic control following initiation or switch of injectable therapies in Tianjin, China: A real‐world retrospective cohort study of adults with type 2 diab... by Qiumei Zhang, Yaqing Fan, Xixi Liu, Minlu Zhang, Jiewen Zhang, Qin Du, Lei Kang, Liming Chen

Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text

Comparative Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists to Dipeptidyl Peptidase 4 Inhibitors in Patients With Heart Failure and Type 2 Diabetes by Takefumi Kishimori, Takao Kato, Atsuyuki Wada, Akira Tani, Ryosuke Yamaji, Jumpei Koike, Yoshihiro Iwasaki, Takehiro Matsumoto, Takafumi Yagi, Masaharu Okada

Subjects: Get full text

Comparative analysis of pharmacokinetic parameters, bioequivalence, safety, tolerability and immunogenicity of semaglutide-based drug for the treatment of obesity by A. S. Ametov, P. A. Bely, K. Y. Zaslavskaya, E. A. Rogozhina, V. S. Shcherbakova, Y. G. Kazaishvili, A. V. Taganov, T. G. Bodrova, E. S. Mishchenko, K. N. Koryanova, L. I. Shcherbakova

Subjects: Get full text

Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli by Cheney C, Hunter K, Klein M

Subjects: Get full text

Dionysus or apollo, skeletal muscle mass changes in type 2 diabetes with sarcopenia receiving GLP-1 receptor agonist: systematic review and meta-analysis by Yanying Wang, Boya Lan, Shuo Zhang, Yue Mu, Jia Mi, Jing Yu, Qun Zhan, Baoling Luo, Fuyang Lin, Jia Teng, Xiuge Wang, Guanchi Yan

Subjects: “…Glucagon-like peptide 1 receptor agonist…”
Get full text

Promising areas of pharmacotherapy for obesity by M. A. Druzhilov, T. Yu. Kuznetsova, G. A. Chumakova

Subjects: Get full text

Characterization of treatment intensified (add‐on to metformin) adults with type 2 diabetes in Thailand: A cross‐sectional real‐world study (CONVERGE) by Chutintorn Sriphrapradang, Ammarin Thakkinstian, Ratiporn Chinthammit, Gurudutt Nayak

Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text

Prior metabolic surgery attenuates the weight-loss efficacy of liraglutide in patients with mild obesity by Yuqin Ouyang, Yuqin Ouyang, Xinyue Xiang, Xinyue Xiang, Xinyun Hu, Xinyun Hu, Xuehui Chu, Wenjuan Tang, Wenjuan Tang, Wenhuan Feng, Wenhuan Feng, Wenhuan Feng

Subjects: “…glucagon-like peptide-1 receptor agonist…”
Get full text

Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure by Khawaja M. Talha, Gregg C. Fonarow, Salim S. Virani, Javed Butler

Subjects: Get full text